Retigabine dihydrochloride osapride Use of cidofovir in progressive

Use of cidofovir in progressive multifocal leukoencephalopathy

3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one

InChi: InChI=1S/C16H13Cl2N3O/c17-12-7-4-8-13(18)14(12)20-16-19-9-10-21(16)15(22)11-5-2-1-3-6-11/h1-8H

Epub 2014 Aug 7

Liesveld JL

Retigabine dihydrochloride osapride Use of cidofovir in progressiveEzogabine, also known as Retigabine, is an anticonvulsant used as an adjunctive treatment for partial epilepsies in treatment experienced adult patients. The drug was developed by Valeant Pharmaceuticals and GlaxoSmithKline. Ezogabine works primarily as a potassium channel openerthat is, by activating a certain family of voltage gated potassium channels in the brain. This mechanism of action is unique among antiepileptic drugs, and may hold promise